Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
30 04 2019
Historique:
received: 25 11 2018
accepted: 18 04 2019
entrez: 2 5 2019
pubmed: 2 5 2019
medline: 19 5 2020
Statut: epublish

Résumé

To evaluate the association between hematological parameters at birth and the risk of moderate-severe bronchopulmonary dysplasia (BPD) in a cohort of extremely preterm infants. This is a retrospective study of all extremely premature infants admitted to the neonatal intensive care unit, Shenzhen Maternity and Child Healthcare Hospital from January 2016 to May 2018. Extremely prematurity was defined as a delivery at a gestational age ≤ 28 weeks or a birth weight ≤ 1000 g. BPD was diagnosed if oxygen exposure exceeded 28 days and the severity was decided at 36 weeks PMA or discharge. Multivariable analysis was performed to assess the independence of the association between hematological parameters at birth and risk of moderate or severe BPD. A total of 115 extremely premature infants were analyzed in this study. The median platelet count, neutrophil and monocyte count at birth were significantly higher in infants with moderate-severe BPD compared to infants without BPD (228 vs 194*10 Our findings suggest that hematologic parameters at birth are different in extremely preterm infants who will develop moderate-severe BPD. A higher platelet count at birth may increase the risk of moderate-severe BPD after extremely premature birth.

Identifiants

pubmed: 31039810
doi: 10.1186/s12887-019-1515-6
pii: 10.1186/s12887-019-1515-6
pmc: PMC6489335
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138

Références

J Pediatr. 2017 Aug;187:3
pubmed: 28750762
Early Hum Dev. 2007 Dec;83(12):789-94
pubmed: 17905543
J Matern Fetal Neonatal Med. 2015;28(18):2197-200
pubmed: 25354286
Pediatrics. 2005 Dec;116(6):1353-60
pubmed: 16322158
Front Med (Lausanne). 2015 Dec 21;2:90
pubmed: 26734611
Am J Perinatol. 2011 Aug;28(7):551-6
pubmed: 21404166
Eur Rev Med Pharmacol Sci. 2013 Jan;17(1):134-7
pubmed: 23329535
JAMA Pediatr. 2015 Feb;169(2):e143676
pubmed: 25642906
Pediatrics. 2008 Jan;121(1):73-81
pubmed: 18166559
Science. 2014 Dec 5;346(6214):1234-8
pubmed: 25477463
Thromb Res. 2017 Mar;151 Suppl 1:S100-S102
pubmed: 28262226
Curr Opin Hematol. 2010 Sep;17(5):418-23
pubmed: 20601870
Blood. 2014 Feb 20;123(8):1250-60
pubmed: 24297866
J Reprod Immunol. 2017 Nov;124:21-29
pubmed: 29035757
Paediatr Respir Rev. 2017 Sep;24:17-18
pubmed: 28697967
J Perinatol. 2003 Sep;23(6):451-6
pubmed: 13679930
Lancet. 2006 Apr 29;367(9520):1421-31
pubmed: 16650652
J Clin Med. 2017 Jan 06;6(1):
pubmed: 28067830
Nature. 2017 Apr 6;544(7648):105-109
pubmed: 28329764
J Perinatol. 2008 Sep;28(9):604-10
pubmed: 18563166
Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22
pubmed: 21471086

Auteurs

Xueyu Chen (X)

Department of Neonatology, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, China.

Huitao Li (H)

Department of Neonatology, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, China.

Xiaomei Qiu (X)

Department of Neonatology, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, China.

Chuanzhong Yang (C)

Department of Neonatology, Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University, Shenzhen, China. yangczgd@163.com.

Frans J Walther (FJ)

Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. fjwalther@ucla.edu.
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. fjwalther@ucla.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH